InsidersTradesSigma
지에프씨생명과학: insider trades · South Korea · DART (FSS)
DART:company-07bd03KR·DART (FSS)Mcap 43.5Bn€Healthcare
Discover the full directors' dealings record of 지에프씨생명과학, a publicly traded company based in South Korea. Shares are quoted on KR KR, under the oversight of DART (FSS). Operating in the Healthcare sector, 지에프씨생명과학 has recorded 6 reports. Market capitalisation: €43.5bn. The latest transaction was disclosed on 10 April 2026 (Purchase). Among the most active insiders: 강희철. The full history is accessible without an account.
6
Insider Decl.
0
Thresholds
€210,842
6 ops.
Buy Volume
·
0 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
8300.00 €
Analyst consensus
Income statement
Revenue17.71 Bn€
Gross profit8.51 Bn€48% margin
Net income555.4 M€3.1% margin
Valuation
Beta0.98
Balance sheet & cash
Market cap43.50 Bn€
Total debt7.52 Bn€
Free Cash Flow−6.34 Bn€
Debt / Equity32%
Profitability & ownership
ROE3.2%
ROA0.9%
% insiders35.5%
% institutions10.2%
Last declaration on 10 April 2026
Declarations6 total
6 of 6 declarations